Search
Patexia Research
Case number 3:19-cv-12845

VALEANT PHARMACEUTICALS NORTH AMERICA LLC et al v. KVK-TECH, INC. > Documents

Date Field Doc. No.Description (Pages)
Nov 8, 2022 1 Complaint* (1)
Jul 15, 2019 11 Order (2)
Docket Text: ORDER Consolidating Civil Action No. 19-12845 and Civil Action No. 18-13635 for all purposes. It is ORDERED that all filings relating to Civil Action 19-12845 are to be made only in Civil Action 18-13635. Signed by Judge Peter G. Sheridan on 7/15/2019. (km)
Jun 19, 2019 10 Answer to Counterclaim (7)
Jun 19, 2019 10 Certificate of Service (2)
Jun 19, 2019 10 Main Document (7)
Docket Text: ANSWER to Counterclaim by DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. (Attachments: # (1) Certificate of Service)(DENI, WILLIAM)
Jun 4, 2019 6 Answer to Complaint (13)
Docket Text:KVK-Tech, Inc.'s ANSWER to Complaint with Defenses and, COUNTERCLAIM against DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC by KVK-TECH, INC..(SLOCUM, CAROL)
Jun 4, 2019 7 Corporate Disclosure Statement (aty) (2)
Docket Text: Corporate Disclosure Statement by KVK-TECH, INC.. (SLOCUM, CAROL)
Jun 4, 2019 8 Notice of Appearance (1)
Docket Text: NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.)
Jun 4, 2019 9 Waiver of Service Executed (1)
Docket Text: WAIVER OF SERVICE Returned Executed by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC. KVK-TECH, INC. waiver sent on 5/31/2019, answer due 7/30/2019. (LOWER, J.)
May 23, 2019 N/A Add and Terminate Judges (0)
Docket Text: Judge Peter G. Sheridan and Magistrate Judge Lois H. Goodman added. (jmh)
May 23, 2019 1 Complaint (9)
May 23, 2019 1 Exhibit A (18)
May 23, 2019 1 Civil Cover Sheet (1)
May 23, 2019 1 L. Civ. R. 11.2 Certification (2)
May 23, 2019 2 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM)
May 23, 2019 3 Corporate Disclosure Statement (aty) (1)
Docket Text: Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM)
May 23, 2019 4 AO120 Patent/Trademark Form (1)
Docket Text: AO120 Patent Form filed. (jmh)
May 23, 2019 5 Summons Issued (2)
Docket Text: SUMMONS ISSUED as to KVK-TECH, INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh)
May 23, 2019 1 Main Document (9)
Docket Text: COMPLAINT against KVK-TECH, INC. ( Filing and Admin fee $ 400 receipt number 0312-9690056), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet, # (3) L. Civ. R. 11.2 Certification)(DENI, WILLIAM)
Menu